Jean-Paul Pirnay

Best Publications

• Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.

  Unknown

  869
  Citations

• Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

  Maya Merabishvili;Jean-Paul Pirnay;Gilbert Verbeken;Nina Chanishvili

  614
  Citations

• Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens

  Yves Briers;Maarten Walmagh;Victor Van Puyenbroeck;Anneleen Cornelissen

  408
  Citations

• Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae

  Unknown

  349
  Citations

• The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

  Jean-Paul Pirnay;Daniel De Vos;Gilbert Verbeken;Maia Merabishvili

  345
  Citations

• Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

  Unknown

  337
  Citations

• Pseudomonas aeruginosa population structure revisited

  Jean-Paul Pirnay;Florence Bilocq;Bruno Pot;Pierre Cornelis

  322
  Citations

• The Magistral Phage.

  Unknown

  319
  Citations

• Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

  Unknown

  278
  Citations

• Quality and Safety Requirements for Sustainable Phage Therapy Products

  Jean-Paul Pirnay;Bob G. Blasdel;Laurent Bretaudeau;Angus Buckling

  271
  Citations

• Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL.

  Danièle De Vos;Antonio Lim Jr.;Jean-Paul Pirnay;Marc Struelens

  257
  Citations

• Experimental phage therapy of burn wound infection: difficult first steps.

  Thomas Rose;Gilbert Verbeken;Daniel De Vos;Maia Merabishvili

  251
  Citations

• Molecular Epidemiology of Pseudomonas aeruginosa Colonization in a Burn Unit: Persistence of a Multidrug-Resistant Clone and a Silver Sulfadiazine-Resistant Clone

  Jean-Paul Pirnay;Danièle De Vos;Christel Cochez;Florence Bilocq

  227
  Citations

• FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa

  Bart Ghysels;Bui Thi Min Dieu;Scott A. Beatson;Jean Paul Pirnay

  222
  Citations

• Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa

  Yves Briers;Maarten Walmagh;Barbara Grymonprez;Manfred Biebl

  220
  Citations

• Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

  Alex R. Hall;Daniel De Vos;Ville-Petri Friman;Ville-Petri Friman;Jean-Paul Pirnay

  205
  Citations

• Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river

  Jean-Paul Pirnay;Sandra Matthijs;Huri Colak;Patrice Chablain

  194
  Citations

• Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

  Christine Rohde;Grégory Resch;Jean-Paul Pirnay;Bob G. Blasdel

  192
  Citations

• Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler

  Unknown

  189
  Citations

• Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium

  Luca Freschi;Julie Jeukens;Irena Kukavica-Ibrulj;Brian Boyle

  170
  Citations